Zacks Research Has Negative Forecast for Avantor Q3 Earnings

Avantor, Inc. (NYSE:AVTR) – Zacks Research reduced their Q3 2026 earnings per share estimates for Avantor in a research note issued on Tuesday, March 25th. Zacks Research analyst D. Dey now expects that the company will post earnings of $0.27 per share for the quarter, down from their prior forecast of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s FY2026 earnings at $1.13 EPS and FY2027 earnings at $1.33 EPS.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the firm earned $0.22 EPS.

Several other equities research analysts have also recently issued reports on AVTR. Wells Fargo & Company lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Raymond James reissued an “outperform” rating and issued a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Citigroup dropped their price objective on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Cowen reissued a “buy” rating on shares of Avantor in a research note on Tuesday, March 18th. Finally, Morgan Stanley lowered their price target on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.50.

Avantor Stock Performance

NYSE AVTR opened at $16.17 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor has a 1-year low of $15.37 and a 1-year high of $28.00. The company has a market cap of $11.01 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The stock’s 50 day simple moving average is $18.52 and its 200-day simple moving average is $21.49.

Institutional Investors Weigh In On Avantor

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares during the last quarter. Global Retirement Partners LLC raised its stake in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after purchasing an additional 1,074 shares during the period. Finally, AlphaQuest LLC purchased a new position in Avantor in the 4th quarter valued at $65,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.